Affiliation:
1. Kharkov National Medical University, Kharkiv, Ukraine
Abstract
Introduction. Polycystic ovary syndrome (PCOS) is one of the most pressing problems in gynecological endocrinology. The aim of the study was to elucidate the morphological changes in the ovaries of rats under various types of hormonal exposure in experimental modeling of PCOS. Materials and methods. To study three working experimental models were developed, associated with the introduction of various hormonal drugs into the body of an animal. Model I-st consisted of subcutaneous administration of an estrogen-containing drug at a dose of 3 mg for 25 days. Model II-d involved the development of PCOS by daily subcutaneous administration of 3 mg of dehydroandrostenediol sulfate. The III model - the formation of PCOS in 5 immature rats using dopamine phytoanalogues at a dose of 3 mg subcutaneously for 25 days. The animals were divided into 3 groups: group 1 - rats that were induced with experimental PCOS and kept in a vivarium at a temperature of +23°C (n=8), group 2 - animals that, against the background of experimental PCOS, were exposed to cold exposure (CE) for 4 hours in a chamber with a constant light regime and a temperature of + 4 °C for 25 days (n = 8); group 3 - intact control (n = 8) - healthy rats without PCOS, which were kept in a vivarium at a temperature of + 23°C. Results. Histological examination of the ovaries of group 1 rats revealed morphological changes in the ovaries characteristic of PCOS. The morphological structure of the ovaries corresponded to type II PCOS. In rats of group 3, macroscopically, the ovaries were slightly reduced in size compared to the control group. The levels of adiponectin and leptin as markers of the functional ovarian tissue of PCOS model experiments.When studying the effect of CE on the body of experimental animals, their effect on the formation of tissue cell hyperplasia as a characteristic sign of PCOS was determined. Conclusions. Studies have shown that the formation of PCOS, as well as structural changes in the ovaries, significantly depend on hormonal regulation disorders.
Publisher
V. N. Karazin Kharkiv National University
Subject
Process Chemistry and Technology,Economic Geology,Fuel Technology
Reference15 articles.
1. Urbanovych AM. Syndrom polikistoznykh yaiechnykiv u shchodennii praktytsi. Mizhnarodnyi endokrynolohichnyi zhurnal. 2018;1(14):40-45. DOI: 10.22141/2224-0721.14.1.2018.127090 [Ukrainian].
2. Couto Alves A, Valcarcel B, Mäkinen VP, Morin-Papunen L, Sebert S, Kangas AJ, et al. Metabolic profiling of polycystic ovary syndrome reveals interactions with abdominal obesity. Int J Obes (Lond). 2017; 41(9):1331-1340. DOI: 10.1038/ijo.2017.126
3. Mogylnytska LA. Vascular endothelial growth factor and endotheliumdependent dilatation in patients with polycystic ovary syndrome whith different body mass. Zhurnal NAMN Ukrayiny`, 2018; Special`ny`j vy`pusk:22-23. [Ukrainian]
4. Kakoly NS, Moran LJ, Teede HJ, Joham AE. Cardiometabolic risks in PCOS: a review of the current state of knowledge. Expert Rev Endocrinol Metab. 2019;14(1):23-33.
5. Dokras A, Stener-Victorin E, Yildiz BO. et al. Androgen Excess-Polycystic Ovary Syndrome Society: position statement on depression, anxiety, quality of life, and eating disorders in polycystic ovary syndrome. Fertil.Steril. 2018;109(5):888-899. DOI: 10.1016/j.fertnstert.2018.01.038